Skip to main content

Outcomes of Same-day Discharge Versus Inpatient Admission with Monitoring After Mastectomy ± Immediate Reconstruction: A Systematic Review and Meta-analysis

Journal
Annals of surgical oncology (Q1)
Published
16 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Ibrahim M, Rossi C, Alnajar A, McKenny M, McKenney C, Cancelli G, et al.
PMID
43040163
DOI
10.1245/s10434-026-20937-1

Why clinicians should know about it

  • Picked for Breast and Endocrine Surgery (top studies of the week, 22 November 2026): Directly informs discharge after mastectomy with or without reconstruction

Abstract

OBJECTIVE: The optimal discharge strategy after mastectomy, with or without reconstruction, remains debated. Same-day discharge has emerged as a potential paradigm shift in postoperative care, driven by Enhanced Recovery After Surgery protocols and value-based, patient-centered care. This study systematically reviews same-day discharge versus inpatient admission after mastectomy and compares outcomes in a meta-analysis. METHOD: MEDLINE, EMBASE, Cochrane Library, and CINAHL were searched for studies comparing same-day discharge versus inpatient admission after mastectomy, with or without reconstruction. Primary outcomes were 30-day readmission and reoperation. Secondary outcomes included postoperative bleeding, wound infection, unplanned ED or clinic visits, and 30-day mortality. Risk of bias was assessed using the Newcastle-Ottawa scale and evidence certainty via GRADE. The protocol was registered on PROSPERO (CRD42024520256). RESULTS: Of 6,377 studies, 18 non-randomized cohort studies encompassing 182,743 patients were included. Same-day discharge was associated with lower odds of reoperation (OR 0.49; 95% CI, 0.41-0.58), postoperative bleeding (OR 0.30; 95% CI, 0.14-0.64), wound infection (OR 0.65; 95% CI, 0.49-0.87), and 30-day mortality (OR 0.07; 95% CI, 0.03-0.19). No significant differences were observed in 30-day readmission (OR 0.96; 95% CI, 0.51-1.81) or unplanned ED or clinic visits (OR 0.62; 95% CI, 0.33-1.16). Certainty of evidence ranged from very low to moderate. CONCLUSIONS: This meta-analysis supports the feasibility of same-day discharge after mastectomy, but underscores the need for high-quality randomized trials to validate these findings.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.